Compounds for the treatment of neurodegenerative and/or cardiovascular diseases

Patent number:

P202430463

Comunidad de Madrid.svg
No items found.

-

Countries:
Spain
Regions:
Community of Madrid
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Son neuroprotectores frente a la alfa-sinucleina en un modelo murino de enfermedad de Parkinson mediante administración intraperitoneal crónica. Se ha demostrado su eficacia frente a inflamación y daño vascular en un modelo murino de daño agudo pulmonar in vivo, inducido por LPS, y en modelos de hipertensión arterial y pulmonar. Administración por vía intra peritoneal u oral. Se han realizado estudios de farmacocinética in vivo mediante administración oral e intra peritoneal.

Comments

Other related patents

Health

METHOD AND KIT FOR EVALUATING THE TOXICITY OF A SAMPLE

Countries
Spain
Know more
Health

Saponins and Chromans Derivatives Mixture Compositions against Leishmaniasis, Trypanosomiasis Americana, Malaria, Trypanosomiasis Africana and Fasciola Hepatica

Countries
Colombia
Know more
Health

Oleuropein in the management of cancer

Countries
Spain
Know more
Get back to patents directory